US Edition
Cutting-edge immunotherapies headline fourth Clinical Trials Plenary - AACR Annual Meeting News
Summary by AACR Meeting News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cutting-edge immunotherapies headline fourth Clinical Trials Plenary - AACR Annual Meeting News
Jedd D. Wolchok, MD, PhD, FAACR Chaired by Jedd D. Wolchok, MD, PhD, FAACR, of Weill Cornell Medicine, and Crystal Mackall, MD, FAACR, of Stanford University, the Biologics and T-cell Engagers Clinical Trials Plenary Session featured updates on four exciting immune-based approaches. Reflecting that the last time he spoke on stage in the McCormick Convention Center’s Arie Crown Theatre was in 2013 when he revealed the results of the first trial …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
